Range
6.65 - 7.33
Vol / Avg.
343K/145.5K
Div / Yield
-
52 Wk
4.8 - 10.67
Mkt Cap
189.6M
Payout Ratio
-
Open
7.15
P/E
-
EPS
-0.12
Shares
26M
Outstanding
26M
Total Float
17.6M
load more
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.130-0.180 -0.0500
REV0
Q4 2020Est.ActualSurprise
EPS-0.130
REV170.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
FENCFennec Pharmaceuticals7.52%189.6M

Fennec Pharmaceuticals Frequently Asked Questions

Q

How do I buy Fennec Pharmaceuticals (FENC) stock?

A

You can purchase shares of Fennec Pharmaceuticals (NASDAQ: FENC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Fennec Pharmaceuticals's (FENC) competitors?

A

There are no as such competitors for Fennec Pharmaceuticals.

Q

What is the target price for Fennec Pharmaceuticals (FENC) stock?

A

The latest price target for Fennec Pharmaceuticals (NASDAQ: FENC) was reported by HC Wainwright & Co. on June 3, 2021. The analyst firm set a price target for 14.00 expecting FENC to rise to within 12 months (a possible 92.04% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Fennec Pharmaceuticals (FENC)?

A

The stock price for Fennec Pharmaceuticals (NASDAQ: FENC) is $7.29 last updated Thu Jun 24 2021 20:00:00 GMT+0000 (Coordinated Universal Time).

Q

Does Fennec Pharmaceuticals (FENC) pay a dividend?

A

There are no upcoming dividends for Fennec Pharmaceuticals. The last dividend paid out to investors was $0.10 on April 22, 2016.

Q

When is Fennec Pharmaceuticals (NASDAQ:FENC) reporting earnings?

A
Fennec Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Fennec Pharmaceuticals (FENC) going to split?

A

There is no upcoming split for Fennec Pharmaceuticals.

Q

What sector and industry does Fennec Pharmaceuticals (FENC) operate in?

A

Fennec Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.